Medtronic to split off its fast-growing diabetes business to unlock its value
The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.
The new diabetes company will be predominantly business-to-consumer, while Medtronic’s model was more business-to-business.
